6533b82efe1ef96bd1293d91
RESEARCH PRODUCT
New pregnane and phenolic glycosides from Solenostemma argel.
Patrick DutartreAnne Claire Mitaine-offerKarima OunaissiaChiaki TanakaStéphanie DelemasureMarie Aleth Lacaille-duboisDavid PertuitTomofumi MiyamotoDalila Smatisubject
Antioxidantmedicine.drug_classmedicine.medical_treatmentAnti-Inflammatory Agents01 natural sciencesPlant RootsAnti-inflammatorychemistry.chemical_compoundPhenolsCell Line TumorDrug DiscoverymedicineOrganic chemistryHumansGlycosidesCytotoxicityPharmacologychemistry.chemical_classificationChromatographyApocynaceaebiologyMolecular Structure010405 organic chemistryPlant ExtractsPregnaneGlycosideGeneral Medicinebiology.organism_classificationPregnanesAntineoplastic Agents Phytogenic0104 chemical sciencesApocynaceae010404 medicinal & biomolecular chemistrychemistryLeukocytes MononuclearTroloxTwo-dimensional nuclear magnetic resonance spectroscopydescription
Abstract From the aerial parts, pericarps and roots of Solenostemma argel, three new pregnane glycosides (1–3) with two known ones and a new phenolic glycoside (4) have been isolated. Their structures were established by extensive 1D – and 2D NMR and mass spectroscopic analysis. The cytotoxicity of all compounds was evaluated against two human tumor cell lines (SW 480, MCF-7), but none of them was active in the concentration range 0.9–59.0 μM. Compounds 2 and the known argeloside F at non toxic concentrations for the PBMCs (27.3 μM and 27.6 μM, respectively) significantly decreased the Il-1β production by LPS-stimulated PBMCs. All isolated compounds showed a significant antioxidant potential with ORAC values in the concentration range 3481–9617 μmol eq. Trolox/100 g.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2016-06-08 | Fitoterapia |